GlassScriptPhysician profile
Hallie Frederick
NPI 1316575913
$2,247.27
in general payments reported to CMS, 2019-2025
32 companies · $894 in 2025
The $894 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $360 · 2024: $873 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $549.54 | 2023-2025 | |
| Gilead Sciences, INC. | $184.09 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $178.70 | 2022-2025 | Airsupra, Farxiga |
| Amgen INC. | $163.05 | 2022-2025 | Krystexxa, Repatha, Otezla |
| Pfizer INC. | $156.78 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.33 | 2023-2025 | Trintellix |
| Lilly USA, LLC | $117.08 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $106.39 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $81.43 | 2023-2025 | Cologuard Collection Kit |
| Emd Serono, INC. | $51.49 | 2024 | |
| Axsome Therapeutics, INC. | $47.63 | 2025 | Symbravo |
| Dexcom, INC. | $40.04 | 2023-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $37.39 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Xeris Pharmaceuticals, INC. | $36.90 | 2023-2024 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $36.66 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $32.20 | 2024 | |
| Merck Sharp & Dohme LLC | $31.33 | 2022 | |
| Currax Pharmaceuticals LLC | $29.39 | 2023-2024 | Contrave, Nexletol, Nexlizet |
| Astellas Pharma US INC | $25.33 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $20.79 | 2024 | Aptima |
| Alk-Abello, INC | $20.71 | 2023 | Grastek, Ragwitek, Odactra |
| Zimmer Biomet Holdings, INC. | $20.06 | 2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Insulet Corporation | $18.83 | 2023 | Omnipod |
| Intra-Sana Laboratories | $18.12 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.20 | 2023 | Jardiance |
| Jazz Pharmaceuticals INC. | $16.59 | 2022 | |
| Halozyme INC | $16.29 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.09 | 2023 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $15.78 | 2025 | |
| Eisai INC. | $14.21 | 2024 | |
| Aurinia Pharma U.S., INC. | $12.70 | 2022 | |
| Phathom Pharmaceuticals, INC. | $8.15 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hallie Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.